Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group-Reference-Cited by-同舟云学术

Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group

Published:2014-07 Issue:1 Volume:91 Page:35-46
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Sodergren Samantha C.,White Alice,Efficace Fabio,Sprangers Mirjam,Fitzsimmons Deborah,Bottomley Andrew,Johnson Colin D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference58 articles.

1. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis;Miettinen;Arch Pathol Lab Med,2006

2. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors;Hirota;Science,1998

3. Update on the biology and therapy of gastrointestinal stromal tumors;D’Amato;Cancer Control,2005

4. Outcome of advanced gastrointestinal stromal tumor (GIST) patients treated with imatinib mesylate: four-year follow-up of a phase II randomized trial;Blanke,2006

5. Gastrointestinal stromal tumour;Joensuu;Lancet,2013

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glassy carbon electrodes modified with graphitic carbon nitride nanosheets and CoNiO2 bimetallic oxide nanoparticles as electrochemical sensor for Sunitinib detection in human fluid matrices and pharmaceutical samples;Microchimica Acta;2024-08-09

2. A case-matched study of imatinib mesylate between different formulations on plasma trough concentration, adverse events, quality of life and outcomes in gastrointestinal stromal tumor patients;PLOS ONE;2024-05-14

3. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study;Oral Oncology;2024-02

4. A patient's perspective on the side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors;Future Oncology;2023-02

5. Oncologic emergencies and urgencies: A comprehensive review;CA: A Cancer Journal for Clinicians;2022-06-02